美国犹他大学是美国犹他州的高等教育旗舰型大学，也是一所世界顶尖的公立研究型大学，为特高研究型大学（Top-tier Research university）。2021U.S. News美国最佳公立大学排名第40位，2022WRWU世界大学排名第63位，2022软科世界大学学术排名第101-150，2022U.S. News世界大学排名第151位。
学生入学可选药学院。犹他大学药学院是本校王牌学科，全美药学院排名#14位（U.S. News）。
Dr. Sixiang Shi Lab招收博士生（全额奖学金）一名，博士后一名，并欢迎访问学者前来一起工作。课题组主要研究分子影像、生物材料、靶向治疗、免疫疗法等方向。Dr. Shi共发表40余篇文章（引用>3900, H因子30），包括 ACS Nano, Advanced Drug Delivery Reviews, Angewandte Chemie, Biomaterials, JNM, Nature Nanotechnology等本领域顶级期刊。担任Journal of Nanobiotechnology（IF=9.429)副主编，并获得 SNMMI Ones to Watch 2020等诸多荣誉。
招生要求：
1.分子影像、生物、化学、材料等相关背景的硕士研究生或者本科四年级学生。
2. 学习成绩优异，有钻研精神。有科研经历和论文发表者优先。
3. 有良好的英文基础，达到托福80分或者雅思6.5分。
研究课题：分子影像、纳米材料、免疫疗法。
有意者请联系sixiang.shi@utah.edu
网页：https://www.blerks.com/
具体招生信息如下：
The Molecular Imaging and Nanotechnology Innovation Laboratory (MINILabs) is seeking graduate students, postdoctoral fellows, and visiting scholars to lead research efforts at the intersection of molecular imaging and nanomedicine. Our core mission is to revolutionize the way we visualize, understand and treat cancer and other diseases, by potentiating simple but powerful solutions to biomedical and healthcare challenges.
Laboratory Research Directions:
1. Application of advanced molecular imaging techniques (PET/CT, optics, optoacoustic imaging, etc.) in cancer, regenerative medicine and other diseases;
2. Development of innovative nanomedicine and natural biomaterials (e.g. extracellular vesicles) for personalized theranostics;
3. Development of novel radiochemistry and targeted radiotherapy for refractory diseases;
4. Utilizing advanced imaging tools to understand the biological unknowns in tumor microenvironment, metastasis, immunology, etc.
Trainees will be a part of a highly multidisciplinary and collaborative group within the Department of Radiology and Imaging Sciences and the Department of Molecular Pharmaceutics at the University of Utah, led jointly by PIs Dr. Shi and Dr. Goel. The excellent academic environment at the University of Utah offers excellent career development and enhancement opportunities at all levels.
Applicant Requirements:
1. Familiarity with advanced techniques in molecular biology, biomedical imaging and biomaterials research is preferred.
2. Successful candidates will be motivated, curious and independent thinkers with a strong sense of responsibility and good oral and written communication skills.
3. Applicants for PhD program should be final-year masters/4th-year undergraduate students or the students who recently graduated.
4. The students exhibiting outstanding performance with excellent GPA and research track record will be given preference.
5. The international students must successfully complete the English Proficiency Test (TOEFL 80 or IELTS 6.5).
6. Applicants for postdoctoral fellows with outstanding publication record and ability to work independently will be given priority.
Contact: Interested candidates are recommended to send their CVs to Dr. Sixiang Shi (sixiang.shi@utah.edu).
Principal Investigator (PI): Dr. Sixiang Shi received his PhD degree in Materials Science and Engineering from the University of Wisconsin-Madison in 2016 and completed his postdoctoral fellowship from MD Anderson Cancer Center in 2020. He shortly worked in the Department of Health Technology and Informatics at the Hong Kong Polytechnic University as an Assistant Professor in 2021. He joined the Department of Radiology and Imaging Sciences at the University of Utah in August 2022. So far, he has published >40 papers (>3900 citations, h-index: 30), in top journals such as ACS Nano, Advanced Drug Delivery Reviews， Angewandte Chemie, Biomaterials, JNM, Nature Nanotechnology, among others. Dr. Shi serves as Associate Editor for Journal of Nanobiotechnology, Editorial Member for Journal of Functional Biomaterials, and reviewer for more than 20 journals, scientific societies, grants agencies and conferences. Dr. Shi has received multiple awards and honors for his research and scholarship, including the SNMMI Ones to Watch 2020, which recognizes most promising researchers worldwide in the fields of nuclear medicine and molecular imaging. Details can be found viahttps://www.blerks.com/.
小编有话说：本文仅作科研人员学术交流，不作任何商业活动。由于小编才疏学浅，不科学之处欢迎批评。如有其他问题请随时联系小编。欢迎关注，点赞，转发，欢迎互设白名单。投稿、荐稿：polyenergy@163.com
版权归原作者所有，删文请联系管理员。发布者：admin，转转请注明出处：https://www.blerks.com/11160.html
